CONMED (CNMD) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 13.2% | 15.7% | 0.75% | 16.8% | 14.7% | 17.8% | ||
Changes by years, y/y, % | +0pp | +3pp | -15pp | +16pp | -2pp | +12.1% |
CONMED. EBITDA margin, %
CONMED. EBITDA margin, changes, pp
CONMED (CNMD) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 18.6% | 18.6% | 17.6% | 14.2% | 20.7% | 17.8% | |
Changes by years, y/y, % | +19pp | +19pp | +13pp | +6pp | +11pp | |||
Changes by quarters, q/q, % | +9pp | 0pp | -1pp | -3pp | +7pp |